Welcome to Farmaprojects, the B2B hub of Polpharma Group. We bring together the power and the agility of a remarkable team with the manufacturing and R&D capabilities of a European market leader.
launches performed per year
0
+
MA approvals in the last decade
0
+
years of experience
0
+
R&D centers
0
+
Our Portfolio
Yes to value creation in generics. Discover our portfolio.
From highly competitive standard oral solids generics to innovative value-added products. Our broad range of medicines covers most therapeutic areas and a diverse range of dosage forms at different development stages. We offer flexible business models to our clients and partners, from out-licensing to co-developments and distribution.
People
Meet our Yes People.
Culture shaping the future of B2B.
At Farmaprojects, we are Yes People. You can expect a company that is currently in transformation, presenting exciting opportunities to shape the future of B2B in the pharmaceutical industry. With headquarters in Barcelona and teams spread internationally, we are a dynamic and diverse company with an entrepreneurial spirit.
R&D
Our state-of-the-art R&D.
The backbone for your success.
As the B2B hub of the Polpharma Group, Farmaprojects unites the agility and attention you expect, with the state-of-the-art R&D capabilities of a European market leader. 5 R&D centers employing more than 370 people innovating at all product levels. Our experienced IP, Quality and RA teams ensure that you launch early, securely and efficiently: they are the backbone for a successful product launch.
Trusted by leading companies worldwide
